Pharmacokinetics and tissue penetration of cefoxitin in obesity: Implications for risk of surgical site infection

Anesthesia and Analgesia

Volumn 113, Issue 4, 2011, Pages 730-737

  Toma, Octavian ^a   Suntrup, Patty ^a   Stefanescu, Andrei ^a   London, Amy ^a   Mutch, Matthew ^b   Kharasch, Evan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN;

ABDOMINAL SUBCUTANEOUS FAT; ABDOMINAL SURGERY; ADIPOSE TISSUE; ADULT; ANTIBIOTIC PROPHYLAXIS; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; HUMAN; INFECTION RISK; MALE; MICRODIALYSIS; MINIMUM INHIBITORY CONCENTRATION; OBESITY; PELVIS SURGERY; PRIORITY JOURNAL; SKIN INCISION; SURGICAL INFECTION; SURGICAL PATIENT; WOUND CLOSURE;

EID: 80053297798     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31821fff74     Document Type: Article

References (45)

1. Rovera F, Diurni M, Dionigi G, Boni L, Ferrari A, Carcano G, Dionigi R. Antibiotic prophylaxis in colorectal surgery. Expert Rev Anti Infect Ther 2005;3:787-95 (Pubitemid 41535400)
2. Stratchounski LS, Taylor EW, Dellinger EP, Pechere JC. Antibiotic policies in surgery: a consensus paper. Int J Antimicrob Agents 2005;26:312-22 (Pubitemid 41338659)
3. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006;43:322-30 (Pubitemid 44088320)
4. Nelson RL, Glenny AM, Song F. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev 2009;1: CD001181
5. ACOG Committee on Practice Bulletins: Gynecology. ACOG practice bulletin no. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2009;113:1180-9
6. Barie PS, Eachempati SR. Surgical site infections. Surg Clin North Am 2005;85:1115-35 (Pubitemid 41744032)
7. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009;37:387-97
8. Mahmoud NN, Turpin RS, Yang G, Saunders WB. Impact of surgical site infections on length of stay and costs in selected colorectal procedures. Surg Infect (Larchmt) 2009;10:539-44
9. Dellinger EP. Prophylactic antibiotics: administration and timing before operation are more important than administration after operation. Clin Infect Dis 2007;44:928-30 (Pubitemid 46452056)
10. Dellinger EP. What is the ideal time for administration of antimicrobial prophylaxis for a surgical procedure? Ann Surg 2008;247:927-8 (Pubitemid 351770412)
11. Wong-Beringer A, Corelli RL, Schrock TR, Guglielmo BJ. Influence of timing of antibiotic administration on tissue concentrations during surgery. Am J Surg 1995;169:379-81
12. Tan JA, Naik VN, Lingard L. Exploring obstacles to proper timing of prophylactic antibiotics for surgical site infections. Qual Saf Health Care 2006;15:32-8 (Pubitemid 43275523)
13. Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, Wright C, Ma A, Carr K, Red L. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140:174-82 (Pubitemid 40229109)
14. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41
15. Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect (Larchmt) 2006;7:473-80 (Pubitemid 44857100)
16. Gendall KA, Raniga S, Kennedy R, Frizelle FA. The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum 2007;50:2223-37 (Pubitemid 350284550)
17. Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 2009;208:53-61
18. Zelenitsky SA, Ariano RE, Harding GK, Silverman RE. Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 2002;46:3026-30
19. Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989;106:750-6
20. Edmiston CE, Krepel C, Kelly H, Larson J, Andris D, Hennen C, Nakeeb A, Wallace JR. Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? Surgery 2004;136:738-47 (Pubitemid 39311298)
21. Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010;49:71-87
22. Bearden DT, Rodvold KA. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics. Clin Pharmacokinet 2000;38:415-26 (Pubitemid 30265261)
23. Siu D. Weighing in on antibiotic dosing in obese patients. Drug Ther Top 2006;35:9-14
24. Chen M, Nafziger AN, Drusano GL, Ma L, Bertino JS Jr. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults. Antimicrob Agents Chemother 2006;50: 1222-7
25. Hollenstein UM, Brunner M, Schmid R, Muller M. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes Relat Metab Disord 2001;25:354-8 (Pubitemid 32209810)
26. Fry DE. Preventive systemic antibiotics in colorectal surgery. Surg Infect (Larchmt) 2008;9:547-52
27. Chaurasia CS, Muller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, Bungay PM, DeLange EC, Derendorf H, Elmquist WF, Hammarlund-Udenaes M, Joukhadar C, Kellogg DL Jr, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H. AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol 2007;47:589-603 (Pubitemid 46632149)
28. Brunner M, Derendorf H, Muller M. Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of antiinfective drugs. Curr Opin Pharmacol 2005;5:495-9 (Pubitemid 41258566)
29. Barbour A, Schmidt S, Rout WR, Ben-David K, Burkhardt O, Derendorf H. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents 2009;34:231-5
30. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet 2005;44:1051-65 (Pubitemid 41356391)
31. Han PY, Duffull SB, Kirkpatrick CM, Green B. Dosing in obesity: a simple solution to a big problem. Clin Pharmacol Ther 2007;82:505-8 (Pubitemid 47622534)
32. DiPiro JT, Vallner JJ, Bowden TA Jr, Clark BA, Sisley JF. Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg 1985;120:829-32 (Pubitemid 15063947)
33. Ko H, Cathcart KS, Griffith DL, Peters GR, Adams WJ. Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination. Antimicrob Agents Chemother 1989;33:356-61 (Pubitemid 19071971)
34. Yost RL, Derendorf H. Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects. Ther Drug Monit 1986;8:189-94 (Pubitemid 16084176)
35. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 2000;39:215-31
36. Jansson PA, Larsson A, Smith U, Lonnroth P. Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest 1992;89:1610-7
37. Bolinder J, Kerckhoffs DA, Moberg E, Hagstrom-Toft E, Arner P. Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 2000;49:797-802 (Pubitemid 30339996)
38. Liu P, Muller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002;19:285-90 (Pubitemid 34308976)
39. Drusano GL. Antimicrobial pharmacodynamics: critical interactions of bug and drug.́ Nat Rev Microbiol 2004;2:289-300 (Pubitemid 39490099)
40. Barry AL, Jones RN. Cross susceptibility and absence of cross resistance to cefotetan and cefoxitin. J Clin Microbiol 1987;25:1570-1 (Pubitemid 17098748)
41. Swenson JM, Brasso WB, Ferraro MJ, Hardy DJ, Knapp CC, Lonsway D, McAllister S, Reller LB, Sader HS, Shortridge D, Skov R, Weinstein MP, Zimmer BL, Patel JB. Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp. J Clin Microbiol 2009;47:1902-5
42. Chopra T, Zhao JJ, Alangaden G, Wood MH, Kaye KS. Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens. Expert Rev Pharmacoecon Outcomes Res 2010;10:317-28
43. Brar MS, Brar SS, Dixon E. Perioperative supplemental oxygen in colorectal patients: a meta-analysis. J Surg Res 2011; 166:227-35
44. Lange KH, Lorentsen J, Isaksson F, Simonsen L, Juul A, Christensen NJ, Kjaer M, Bulow J. Subcutaneous abdominal adipose tissue lipolysis during exercise determined by arteriovenous measurements in older women. J Am Geriatr Soc 2002;50:275-81 (Pubitemid 34132427)
45. Treschan TA, Taguchi A, Ali SZ, Sharma N, Kabon B, Sessler DI, Kurz A. The effects of epidural and general anesthesia on tissue oxygenation. Anesth Analg 2003;96:1553-7 (Pubitemid 36623105)